Corporate Banner
Satellite Banner
Cell Culture
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Webinar on Oncology Applications of RAFT 3D Cell Culture

Published: Thursday, October 24, 2013
Last Updated: Wednesday, October 23, 2013
Bookmark and Share
UCL and TAP Biosystems’ experts discuss 3D cell culture for effective cancer targeting.

TAP Biosystems has announced that it will be running a new webinar on Wednesday November 6th, offering free access to scientific presentations on the benefits of using its innovative RAFT™ 3D collagen-based cell culture technology in oncology research.

Two 3D cell culture experts, Dr Marilena Loizidou, Senior Lecturer in Cancer Nanotechnology at UCL Division of Surgery and Interventional Science and Dr Grant Cameron, RAFT Development Director at TAP Biosystems will be presenting data on the RAFT 3D cell culture technology and how it can be utilized to improve results in a number of pre-clinical oncology research applications at two, live webinars on Wednesday November 6th at 11am GMT and 4pm GMT.

To join the webinars, scientists simply need to register at: http://www.tapbiosystems.com/RAFT_webinar/regsiter_corp.asp.

During the hour long webinars, Dr Loizidou will discuss how 3D cancer cultures are emerging as a more pathologically-relevant in vitro model than 2D cultures, and how they can be engineered using the RAFT collagen-based technology to mimic the tissue heterogeneity of in vivo solid tumours.

Dr Loizidou will also present data on how RAFT generated 3D cancer models can be used for therapeutic investigations or developed as imaging phantoms.

Dr Cameron will discuss the use 3D collagen based cell cultures to produce dose response curves and to study cell signalling, target modulation and mitochondrial function with data comparisons between 2D cell culture techniques and RAFT generated 3D cell cultures.

Dr Cameron will also provide a brief overview of additional application areas where 3D cell culture is adding value such as improving maturation of iPS hepatocytes over extended culture periods.

Dr Grant Cameron, TAP Biosystems’ RAFT Development Director explained: “There is an increasing demand for realistic 3D cell culture models in oncology research because working with a more physiologically relevant, reproducible cellular environment has the potential for reducing risk in oncology screening by improving translational results.”

Cameron added: “I am privileged to be hosting a webinar alongside such a well respected oncology expert as Dr Marilena Loizidou. It is a great opportunity for existing 3D cell culture advocates and researchers evaluating 3D cell culture to meet. We look forward to discussing the benefits of routinely incorporating the RAFT 3D cell culture process into oncology screening programmes with scientists that join us for these informative webinars on November 6th.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Merck and TAP Biosystems Finalists for “Best Collaboration Award”
Recognizing ambr250 as a breakthrough technology for process development.
Wednesday, October 08, 2014
TAP and Gallus Co-host Free Webinar
Explaining the benefits of using ambr15 microbioreactors for DoE.
Wednesday, October 01, 2014
New Webinars Explore Feed Strategy Challenges Using Mini Bioreactors
Detailing how to achieve consistent feeding regimes for reproducible scale-up.
Thursday, September 25, 2014
New Webinar on Mimicking Perfusion Culture Using Micro Bioreactors
Presents validation data for improving media screening and process optimization.
Friday, February 14, 2014
TAP Biosystems Presents New Data on 3D Cell Culture Research
Discussing the application of RAFT 3D models in oncology, toxicology and neuroscience cell-based screening programmes.
Monday, January 20, 2014
Collaboration between TAP Biosystems and UCL to Develop Biomimetic 3D Cancer Models
TAP Biosystems announced new collaboration to develop solid tumour tissue models using its RAFT 3D cell culture system for use in drug discovery applications.
Friday, October 12, 2012
Scientific News
Women’s Immune System Genes Operate Differently from Men’s
A new technology reveals that immune system genes switch on and off differently in women and men, and the source of that variation is not primarily in the DNA.
DNA Damage Seen in Patients Undergoing CT Scanning
Along with the burgeoning use of advanced medical imaging tests over the past decade have come rising public health concerns about possible links between low-dose radiation and cancer.
Yeast Cells Use Signaling Pathway to Modify Their Genomes
Researchers at the Babraham Institute and Cambridge Systems Biology Centre, University of Cambridge have shown that yeast can modify their genomes to take advantage of an excess of calories in the environment and attain optimal growth.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
New Measurements Reveal Differences Between Stem Cells for Treating Retinal Degeneration
By growing two types of stem cells in a “3-D culture” and measuring their ability to produce retinal cells, a team lead by St. Jude Children’s Research Hospital researchers has found one cell type to be better at producing retinal cells.
Researchers Identify Critical Genes Responsible for Brain Tumor Growth
After generating new brain tumor models scientists have identified the role of a family of genes underlying tumor growth in a wide spectrum of high grade brain tumors.
Growing Spinal Disc Tissue
Scientists develop new method for growing spinal disc tissue in the lab for combating chronic back pain.
A New Path Towards a Universal Flu Vaccine
New research suggests it may be possible to harness a previously unknown mechanism within the immune system to create more effective and efficient vaccines against this ever-mutating virus.
Potential New Class of Cancer Drugs
Scientists have found a way to stop cancer cell growth by targeting the Warburg Effect, a trait of cancer cell metabolism that scientists have been eager to exploit.
Human Trials of Manufactured Blood Within Two Years
The first human trials of lab-produced blood to help create better-matched blood for patients with complex blood conditions has been announced by NHS Blood and Transplant.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!